French Society of Mammography and Breast Pathology
Primary prevention trial of breast cancer by tamoxifen: the position of the French Society of Mammography and Breast Pathology
Source and rights
Published by Journal de gynecologie, obstetrique et biologie de la reproduction, 1994. The guideline itself is at the source linked here.
Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.
At a glance
- Organisation
- French Society of Mammography and Breast Pathology
- Published
- 1994
- Applies to
- 🇫🇷 France
- Scope
- National
- Journal
- Journal de gynecologie, obstetrique et biologie de la reproduction
- PubMed
- 7995922
- Added to Prognia
- 24 July 2026
More in oncology
- Non-Small Cell Lung Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In OncologyNational Comprehensive Cancer Network · 2026
- Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Settings (2025 Update)Research Excellence, Active Leadership Canadian Breast Cancer Alliance (REAL Alliance) [2] · 2026
